US EditionPlexāā Closes $4.5 Million Funding Extension to Drive U.S. Launch of BLOOM43 Platform for Breast Surgery
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
Plexāā Closes $4.5 Million Funding Extension to Drive U.S. Launch of BLOOM⁴³ Platform for Breast Surgery
LONDON--(BUSINESS WIRE)--#breastsurgery--Plexāā, a MedTech startup behind the award-winning BLOOM⁴³ medical device for breast surgery, has announced the close of a $4.5 million funding extension round. The strategic capital infusion will support the im... L'articolo Plexāā Closes $4.5 Million Funding Extension to Drive U.S. Launch of BLOOM⁴³ Platform for Breast Surgery è un contenuto originale di 01net.
Plexāā Closes $4.5M Extension to Bring Wearable Device for Breast Cancer Surgery to U.S.
What You Should Know: – Plexāā, a pioneering UK-based MedTech startup behind the award-winning BLOOM⁴³ medical device for breast surgery closes $4.5M funding extension round led by TCP Health Ventures. The extension round includes both existing and new investors, including TCP. Further investment comprises over $1.6M in i4i grant funding from the National Institute for Health and Care Research (NIHR), and $1.3M from Thena Capital, a London-base…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
